Kymera Therapeutics' KT-474, a candidate for immune-inflammatory diseases such as atopic dermatitis and rheumatoid arthritis, demonstrated proof-of-biology and cytokine inhibition.
Mean IRAK4 degradation of up to 96% in PBMC and up to 97% inhibition of ex vivo induction of multiple proinflammatory cytokines observed, suggesting potential for broad...
WATERTOWN, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ:KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Neutral |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 148.85 | 149.73 | 148.49 | -0.47 | -0.31% | 53.87M | NASDAQ | |||
| 2,924.40 | 2,973.00 | 2,788.10 | +138.2 | +4.96% | 4.20M | NASDAQ | |||
| 312.22 | 319.25 | 312.06 | -3.59 | -1.14% | 29.54M | NASDAQ | |||
| 15.51 | 15.92 | 15.50 | -0.43 | -2.70% | 77.47M | NYSE | |||
| 1.50 | 1.98 | 1.27 | +0.3200 | +27.12% | 85.75M | NASDAQ | |||
| 47.89 | 48.82 | 47.87 | -0.39 | -0.81% | 40.74M | NASDAQ | |||
| 20.02 | 20.78 | 19.87 | -0.92 | -4.39% | 2.11M | NASDAQ | |||
| 55.52 | 56.08 | 55.26 | +1.05 | +1.93% | 23.63M | NYSE | |||
| 25.06 | 25.48 | 25.04 | -0.31 | -1.22% | 39.81M | NYSE | |||
| 167.75 | 170.79 | 166.13 | -1.08 | -0.64% | 2.26M | NASDAQ | |||
| 311.67 | 320.28 | 306.50 | -7.82 | -2.45% | 5.20M | NASDAQ | |||
| 178.24 | 182.34 | 178.08 | -3.92 | -2.15% | 2.62M | NYSE | |||
| 176.95 | 184.16 | 173.81 | -7.05 | -3.83% | 830.78K | NYSE | |||
| 42.97 | 43.56 | 42.68 | -0.59 | -1.35% | 21.85M | NYSE | |||
| 244.36 | 250.90 | 242.82 | -2.81 | -1.14% | 24.26M | NASDAQ |
KT Corp is a Korea-based company that mainly provides telecommunication services. The Company operates its business through four segments. The Information and Communications Technologies segment is engaged in providing telecommunication services to individual, home, corporate customers and the convergence business. The Finance segment is engaged in providing financial services, such as credit card. The Satellite Broadcasting segment provides satellite television services. The Other segment includes security services, satellite service, information technology and network services, as well as global business services, which provide global network services to multinational or domestic corporate customers and telecommunications companies. The Company's principal services include mobile voice and data telecommunications services; fixed-line services; credit card processing and other financial services; as well as other services.